The United Laboratories International Holdings Limited

The United Laboratories International Holdings Limited - Enterprise Valueverified

ULIHF

Price:

$1.24

Market Cap:

$14.08B

The United Laboratories International Holdings Limited functions as a pharmaceutical investment holding company, overseeing the entire spectrum of drug-related activities from initial research and development to manufacturing, distribution, and sales. Its business operations are structured into three main divisions: Bulk Medicine, Intermediate Products, and Finished Products. The company offers a diverse portfolio of medicinal products, including oral and injectable antibiotics, anti-cold and cough remedies, ophthalmic treatments, antiviral drugs, solutions for hepatitis B and diabetes, external dermatological preparations, cardiovascular, cerebrovascular, and nervous system medications, as ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-11-03

Stock Exchange

OTC

Ticker

ULIHF

The Enterprise Value as of June 2026 (TTM) for The United Laboratories International Holdings Limited (ULIHF) is 7.84B

According to The United Laboratories International Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 7.84B. This represents a change of -49.82% compared to the average of 15.62B of the last 4 quarters.

The United Laboratories International Holdings Limited (ULIHF) Historical Enterprise Value (quarterly & annually)

How has ULIHF Enterprise Value performed in the past?

The mean historical Enterprise Value of The United Laboratories International Holdings Limited over the last ten years is 10.12B. The current 7.84B Enterprise Value has changed 7.65% with respect to the historical average. Over the past ten years (40 quarters), ULIHF's Enterprise Value was at its highest in in the June 2025 quarter at 21.01B. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

Quarterly (TTM)
Annual

Average

10.12B

Median

9.76B

Minimum

5.04B

Maximum

17.92B

The United Laboratories International Holdings Limited (ULIHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of The United Laboratories International Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 97.33%

Maximum Annual Enterprise Value = 17.92B

Minimum Annual Increase = -31.70%

Minimum Annual Enterprise Value = 5.04B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202513.38B-25.33%
202417.92B97.33%
20239.08B62.33%
20225.59B10.87%
20215.04B-31.70%
20207.39B-27.26%
201910.15B8.35%
20189.37B-21.27%
201711.90B4.90%
201611.35B11.00%

The United Laboratories International Holdings Limited (ULIHF) Average Enterprise Value

How has ULIHF Enterprise Value performed in the past?

The current Enterprise Value of The United Laboratories International Holdings Limited (ULIHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

13.46B

5-year avg

10.20B

10-year avg

10.12B

The United Laboratories International Holdings Limited (ULIHF) Enterprise Value vs. Peers

How is ULIHF’s Enterprise Value compared to its peers?

The United Laboratories International Holdings Limited’s Enterprise Value is less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (11.94B), less than Santen Pharmaceutical Co., Ltd. (521.97B), less than Livzon Pharmaceutical Group Inc. (20.89B), less than Shandong Weigao Group Medical Polymer Company Limited (9.48B), greater than HUTCHMED (China) Limited (1.83B), less than Sumitomo Pharma Co., Ltd. (832.08B), less than Sumitomo Pharma Co., Ltd. (832.08B), less than Hypera S.A. (20.64B), less than MediPal Holdings Corporation (241.40B), greater than Ansell Limited (3.63B),

Build a custom stock screener for The United Laboratories International Holdings Limited (ULIHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like The United Laboratories International Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

The United Laboratories International Holdings Limited (ULIHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like The United Laboratories International Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is The United Laboratories International Holdings Limited's Enterprise Value?

What is the highest Enterprise Value for The United Laboratories International Holdings Limited (ULIHF)?

What is the 3-year average Enterprise Value for The United Laboratories International Holdings Limited (ULIHF)?

What is the 5-year average Enterprise Value for The United Laboratories International Holdings Limited (ULIHF)?

How does the current Enterprise Value for The United Laboratories International Holdings Limited (ULIHF) compare to its historical average?